Becton, Dickinson and Company (BDX) Stake Lessened by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. cut its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 4.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,649 shares of the medical instruments supplier’s stock after selling 1,619 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Becton, Dickinson and were worth $6,955,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of BDX. North Star Investment Management Corp. increased its position in shares of Becton, Dickinson and by 3.4% in the 1st quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock valued at $101,000 after acquiring an additional 18 shares during the period. Almanack Investment Partners LLC. acquired a new position in shares of Becton, Dickinson and in the 1st quarter valued at $105,000. Parkside Financial Bank & Trust increased its position in shares of Becton, Dickinson and by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after acquiring an additional 9 shares during the period. QCI Asset Management Inc. NY increased its position in shares of Becton, Dickinson and by 9.2% in the 1st quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock valued at $130,000 after acquiring an additional 60 shares during the period. Finally, Financial Architects Inc increased its position in shares of Becton, Dickinson and by 8.0% in the 2nd quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock valued at $142,000 after acquiring an additional 54 shares during the period. 87.43% of the stock is currently owned by institutional investors and hedge funds.

Several equities analysts recently issued reports on the company. BidaskClub raised Becton, Dickinson and from a “hold” rating to a “buy” rating in a research report on Monday, August 14th. Cowen and Company reissued a “buy” rating and issued a $230.00 target price on shares of Becton, Dickinson and in a research report on Monday, August 14th. Barclays PLC reissued an “equal weight” rating and issued a $210.00 target price (up from $205.00) on shares of Becton, Dickinson and in a research report on Thursday, August 10th. Stifel Nicolaus reissued a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Finally, Zacks Investment Research downgraded Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Monday, August 7th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $195.79.

TRADEMARK VIOLATION WARNING: “Becton, Dickinson and Company (BDX) Stake Lessened by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.” was reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.themarketsdaily.com/2017/09/11/becton-dickinson-and-company-bdx-stake-lessened-by-mitsubishi-ufj-kokusai-asset-management-co-ltd.html.

In other Becton, Dickinson and news, insider Gary M. Cohen sold 15,044 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $200.43, for a total value of $3,015,268.92. Following the sale, the insider now owns 95,270 shares of the company’s stock, valued at $19,094,966.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ellen R. Strahlman sold 9,283 shares of the company’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $198.21, for a total transaction of $1,839,983.43. Following the completion of the sale, the insider now directly owns 26,638 shares in the company, valued at approximately $5,279,917.98. The disclosure for this sale can be found here. Insiders sold 48,605 shares of company stock worth $9,718,986 in the last ninety days. Insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company (NYSE BDX) opened at 203.70 on Monday. The company’s 50 day moving average is $200.12 and its 200 day moving average is $190.74. The firm has a market cap of $46.35 billion, a P/E ratio of 58.99 and a beta of 1.06. Becton, Dickinson and Company has a 52-week low of $161.29 and a 52-week high of $206.63.

Becton, Dickinson and (NYSE:BDX) last released its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.02. The firm had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.06 billion. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm’s revenue was down 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.35 earnings per share. Equities research analysts forecast that Becton, Dickinson and Company will post $9.46 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be issued a $0.73 dividend. This represents a $2.92 annualized dividend and a dividend yield of 1.43%. The ex-dividend date of this dividend is Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 83.43%.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply